• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • NMPA Proposes to Expand the Scope for the Class I Medical Device Classification Catalogue

NMPA Proposes to Expand the Scope for the Class I Medical Device Classification Catalogue

Tuesday, 28 September 2021 / Published in Medical Device, News, NMPA Registration in China

NMPA Proposes to Expand the Scope for the Class I Medical Device Classification Catalogue

On August 18, 2021, the NMPA (National Medical Products Administration) released the revised draft of the Class I Medical Device Classification Catalogue to solicit public comments.

Apart from the Medical Device Classification Catalogue that was published by the State Food and Drug Administration (former NMPA) in 2017, there are different documents that can be referred to for the classification and product definition of class I medical devices, including the Class I Medical Device Classification Catalogue.

Due to the emergence of new technologies, products and materials in the medical device industry over the past years, the NMPA added 600 new product examples in the proposed catalogue to cover a total of 2689 products.

Highlights

Features of the new proposed Class I Medical Device Classification Catalogue:

  • Same framework as the 2017 version
  • Retention of product information in principle for Class I medical devices under five specific product categories from the 2017 version
  • The names of the 600 new product examples added to the proposed catalogue that also comply with the NMPA Guidelines for Nomenclature for Common Names of Medical Devices
  • The proposed catalogue no longer includes IVDs and combination products
  • A list of prohibited ingredients for Class I medical device products was added in the appendix

By Nina Yan. Contact Cisema if you would like to learn more.

Tagged under: Class I Medical Device, Classification Catalogue

What you can read next

DISINFECTANTS IN CHINA: APPROVAL PROCESS AND REVISED STANDARDS
New NMPA Guidelines on Periodic Risk Evaluation Reports (PRER) for Medical Device Adverse Events
First GLP Accredited Laboratory in China for Biocompatibility Testing

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.